Pain, Opioids and Pro-Inflammatory Immune Responses

Clinical trial NCT01210066 · TERMINATED

Trial details

NCT number: NCT01210066
Sponsor: University of California, Los Angeles
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Pro-inflammatory Activity Immunologic Activity Alteration

Start date: 2010-07-01
Primary completion: 2012-05-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.